GeneDx Ownership | Who Owns GeneDx?


OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary


GeneDx is owned by 102.20% institutional investors, 12.26% insiders. Corvex management lp is the largest institutional shareholder, holding 10.70% of WGS shares.

WGS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGeneDx102.20%12.26%-14.46%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryHealthcare Information Services Stocks 41.37%12.81%45.81%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corvex management lp3.06M10.70%$329.54M
Casdin capital3.01M10.52%$323.99M
Blackrock funding, inc. /de1.53M5.35%$164.74M
William blair investment management1.22M4.27%$131.46M
Vanguard group1.17M4.10%$126.10M
Goldman sachs group1.17M4.09%$125.86M
Oracle investment management922.45K3.23%$85.15M
Summit partners public asset management823.57K2.88%$88.73M
T. rowe price investment management718.00K2.51%$77.36M
Franklin resources681.38K2.38%$73.41M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management922.45K58.40%$85.15M
Casdin capital3.01M27.01%$323.99M
Alamea verwaltungs gmbh195.99K14.43%$21.12B
Corvex management lp3.06M10.93%$329.54M
Gagnon advisors127.06K8.45%$13.69M
Science & technology partners224.07K6.73%$24.14M
Gagnon securities269.07K5.82%$28.99M
Zweig-dimenna associates602.30K4.54%$64.89M
Palisades investment partners84.74K3.58%$9.13M
Legal advantage investments60.65K2.94%$6.53M

Top Buyers

HolderShares% AssetsChange
Ark investment management446.98K0.29%446.98K
Franklin resources681.38K0.02%343.95K
Fmr503.31K0.00%339.99K
Price t rowe associates inc /md/331.41K0.00%316.35K
Nikko asset management americas292.25K0.30%292.25K

Top Sellers

HolderShares% AssetsChange
Ubs group149.79K0.00%-851.93K
Pentwater capital management lp425.00K0.26%-795.00K
Millennium management58.80K0.00%-515.63K
Casdin capital3.01M27.01%-500.00K
Fred alger management357.30K0.15%-463.22K

New Positions

HolderShares% AssetsChangeValue
Ark investment management446.98K0.29%446.98K$48.16B
Sumitomo mitsui trust292.25K0.02%292.25K$31.49M
Nikko asset management americas292.25K0.30%292.25K$31.44M
Capital investors100.28K0.00%100.28K$10.80M
Jane street group92.29K0.00%92.29K$9.94B

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Mai capital management-1.00
Mather group, llc.-2.00
Org partners-5.00
Allworth financial lp-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202528216.53%29,207,814-0.14%1020.98%1513.42%8450.00%
Jun 30, 20252481.64%31,311,68210.33%1091.08%146-0.68%60-1.64%
Mar 31, 202524215.24%28,417,95020.78%1001.34%144-4.64%6272.22%
Dec 31, 202419836.55%21,822,46915.86%801.67%14145.36%3332.00%
Sep 30, 202414557.61%18,835,00115.66%691.86%9746.97%25127.27%

Recent Insider Transactions


DateNameRoleActivityValue
Dec 09, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$201.65K
Dec 09, 2025Stueland Katherine CHIEF EXECUTIVE OFFICERSell$579.62K
Dec 01, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$61.28K
Nov 24, 2025RUCH JOSHUA-Sell$319.34K
Nov 24, 2025RUCH JOSHUA-Sell$1.44M

Insider Transactions Trends


DateBuySell
2025 Q4-21
2025 Q3-39
2025 Q2537
2025 Q1-30
2024 Q4-38

WGS Ownership FAQ


Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 102.20%, followed by 12.26% insiders and -14.46% retail investors. The average institutional ownership in GeneDx's industry, Healthcare Information Services Stocks , is 41.37%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Corvex management lp (3.06M shares, 10.70%), Casdin capital (3.01M shares, 10.52%), and Blackrock funding, inc. /de (1.53M shares, 5.35%). Together, they hold 26.57% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Oracle investment management is GeneDx’s biggest shareholder by percentage of total assets invested, with 58.40% of its assets in 922.45K GeneDx shares, valued at 85.15M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools